A study found that cholesterol absorption inhibitors are linked to a 31% lower risk of liver cancer, confirming similar benefits seen with statins, while other non-statin drugs showed no clear effect… [+2823 chars]
Non-Statin Cholesterol-Lowering Drug Linked to Lower Cancer Risk - SciTechDaily
Cholesterol absorption inhibitors, like statins, are associated with a reduced risk of developing liver cancer. Previous research has indicated that statins, cholesterol-lowering medications, may reduce the risk of developing liver cancer. In a new study publ…
Source:SciTechDaily
Published:
Related News
Study Reveals How Much Exercise You Need Weekly To Control Blood Pressure - ScienceAlert
When it comes to exercising for your heart's sake, you don't want to peak too early in life.
ScienceAlert•Clare Watson
Scientists May Have Found a Blueprint to Revive Old Cells - ScienceAlert
Many of the body's processes slow down or falter as we get older, including tissue regeneration.
ScienceAlert•David Nield
San Francisco reports first flu deaths of the season as cases rise across California - San Francisco Chronicle
San Francisco on Friday announced the city’s first two flu deaths of the winter respiratory virus season, as cases rise across California.
San Francisco Chronicle•Catherine Ho